SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001214659-22-009141
Filing Date
2022-07-25
Accepted
2022-07-25 16:00:19
Documents
2
Group Members
KEVIN TANGTANG CAPITAL MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 p722221sc13g.htm SC 13G 83515
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 7451
  Complete submission text file 0001214659-22-009141.txt   92555
Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
TANG CAPITAL PARTNERS LP (Filed by) CIK: 0001191935 (see all company filings)

IRS No.: 680517277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Subject) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89140 | Film No.: 221103308
SIC: 2834 Pharmaceutical Preparations